| Primary |
| Prophylaxis |
23.7% |
| Graft Versus Host Disease |
9.6% |
| Drug Use For Unknown Indication |
7.8% |
| Hypertension |
7.8% |
| Infection Prophylaxis |
6.8% |
| Multiple Sclerosis |
6.0% |
| Prophylaxis Against Graft Versus Host Disease |
5.2% |
| Thrombosis Prophylaxis |
4.4% |
| Prophylaxis Against Transplant Rejection |
4.1% |
| Renal Transplant |
4.1% |
| Therapeutic Procedure |
3.9% |
| Anxiety |
3.0% |
| Liver Transplant |
2.5% |
| Sedation |
2.5% |
| Antifungal Prophylaxis |
1.7% |
| Immunosuppression |
1.4% |
| Insomnia |
1.4% |
| Nausea |
1.4% |
| Pneumonia |
1.4% |
| Hepatitis C |
1.3% |
|
| Urinary Tract Infection |
19.6% |
| Sepsis |
18.4% |
| Cytomegalovirus Infection |
9.2% |
| Urosepsis |
8.6% |
| Pneumonia |
6.1% |
| Pyrexia |
3.7% |
| Rash |
3.7% |
| Gastroenteritis |
3.1% |
| Herpes Zoster |
3.1% |
| Pyelonephritis |
3.1% |
| Human Polyomavirus Infection |
2.5% |
| Pancytopenia |
2.5% |
| Peritonitis |
2.5% |
| Vomiting |
2.5% |
| Wound Dehiscence |
2.5% |
| Bk Virus Infection |
1.8% |
| Death |
1.8% |
| Febrile Neutropenia |
1.8% |
| Graft Versus Host Disease |
1.8% |
| Hepatitis C |
1.8% |
|
| Secondary |
| Prophylaxis Against Renal Transplant Rejection |
24.9% |
| Prophylaxis Against Transplant Rejection |
22.9% |
| Renal Transplant |
12.4% |
| Prophylaxis |
6.6% |
| Graft Versus Host Disease |
4.5% |
| Product Used For Unknown Indication |
4.4% |
| Drug Use For Unknown Indication |
3.7% |
| Immunosuppression |
3.5% |
| Hypertension |
2.4% |
| Infection Prophylaxis |
2.4% |
| Prophylaxis Against Graft Versus Host Disease |
1.8% |
| Sedation |
1.7% |
| Acute Graft Versus Host Disease |
1.5% |
| Thrombosis Prophylaxis |
1.3% |
| Therapeutic Procedure |
1.2% |
| Anti-infective Therapy |
1.1% |
| Lung Transplant |
1.1% |
| Immunosuppressant Drug Therapy |
1.0% |
| Antifungal Prophylaxis |
0.9% |
| Anxiety |
0.9% |
|
| Urinary Tract Infection |
21.1% |
| Sepsis |
8.6% |
| Ureteric Stenosis |
7.1% |
| Urosepsis |
6.8% |
| Lymphocele |
5.7% |
| Weight Decreased |
5.0% |
| Cytomegalovirus Infection |
4.6% |
| Transplant Rejection |
4.6% |
| Urinary Retention |
4.3% |
| Wound Dehiscence |
4.3% |
| Pneumonia |
3.6% |
| Vomiting |
3.6% |
| Wound Infection |
3.2% |
| Pyrexia |
2.9% |
| Urinary Tract Infection Pseudomonal |
2.9% |
| Diarrhoea |
2.5% |
| Gastric Ulcer |
2.5% |
| Renal Impairment |
2.5% |
| Gastroenteritis |
2.1% |
| Human Polyomavirus Infection |
2.1% |
|
| Concomitant |
| Prophylaxis Against Transplant Rejection |
50.4% |
| Product Used For Unknown Indication |
11.5% |
| Renal Transplant |
9.9% |
| Immunosuppression |
3.8% |
| Drug Use For Unknown Indication |
3.5% |
| Prophylaxis Against Graft Versus Host Disease |
3.4% |
| Immunosuppressant Drug Therapy |
2.6% |
| Heart Transplant |
2.4% |
| Multiple Sclerosis |
2.1% |
| Infection Prophylaxis |
1.6% |
| Osteopenia |
1.4% |
| Glioblastoma |
1.3% |
| Fusarium Infection |
1.0% |
| Hypertension |
1.0% |
| Intestinal Transplant |
1.0% |
| Antiphospholipid Syndrome |
0.8% |
| Bone Marrow Conditioning Regimen |
0.8% |
| Graft Versus Host Disease |
0.6% |
| Acute Graft Versus Host Disease |
0.5% |
| Analgesia |
0.5% |
|
| Urinary Tract Infection |
15.7% |
| Transplant Rejection |
8.6% |
| Urinary Retention |
7.1% |
| Wound Dehiscence |
7.1% |
| Sepsis |
5.7% |
| Thrombocytopenia |
5.7% |
| Urinary Tract Infection Enterococcal |
5.7% |
| Vesical Fistula |
5.7% |
| Cytomegalovirus Infection |
4.3% |
| Retroperitoneal Haematoma |
4.3% |
| Wound Treatment |
4.3% |
| Bone Marrow Failure |
2.9% |
| Cerebrovascular Accident |
2.9% |
| Diabetes Mellitus |
2.9% |
| Focal Segmental Glomerulosclerosis |
2.9% |
| Kidney Transplant Rejection |
2.9% |
| Lung Disorder |
2.9% |
| Mantle Cell Lymphoma Stage Iv |
2.9% |
| Maternal Exposure During Pregnancy |
2.9% |
| Renal Impairment |
2.9% |
|
